Importance of kynurenine in pulmonary hypertension

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 313, Issue 5, 2017, Pages L741-L751

  Nagy, Bence M ^a,b   Nagaraj, Chandran ^a,b   Meinitzer, Andreas ^b   Sharma, Neha ^b   Papp, Rita ^a   Foris, Vasile ^a,b   Ghanim, Bahil ^a,c   Kwapiszewska, Grazyna ^a,b   Kovacs, Gabor ^a,b   Klepetko, Walter ^c   Pieber, Thomas R ^b   Mangge, Harald ^b   Olschewski, Horst ^a,b   Olschewski, Andrea ^a,b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Circulating metabolite; Kynurenine; Laser capture microdissection; Pulmonary hypertension; Vasodilation

Indexed keywords

BIOLOGICAL MARKER; CYCLIC AMP; CYCLIC GMP; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENIC ACID; KYNURENINE; NITRIC OXIDE; TRYPTOPHAN; VASODILATOR AGENT;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG HEMODYNAMICS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; RAT; VASODILATATION; YOUNG ADULT; AGED; ANIMAL; C57BL MOUSE; CHILD; CHRONIC DISEASE; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SMOOTH MUSCLE CELL;

ADOLESCENT; ADULT; AGED; ANIMALS; CHILD; CHRONIC DISEASE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; KYNURENINE; LUNG; MALE; MICE, INBRED C57BL; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; VASODILATOR AGENTS; YOUNG ADULT;

EID: 85032943326     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00517.2016     Document Type: Article

References (27)

1. Changsirivathanathamrong D, Wang Y, Rajbhandari D, Maghzal GJ, Mak WM, Woolfe C, Duflou J, Gebski V, dos Remedios CG, Celermajer DS, Stocker R. Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. Crit Care Med 39: 2678-2683, 2011. doi:10.1097/CCM.0b013e31822827f2.
2. Chen Y, Guillemin GJ. Kynurenine pathway metabolites in humans: disease and healthy States. Int J Tryptophan Res 2: 1-19, 2009.
3. Evgenov OV, Pacher P, Schmidt PM, Haskó G, Schmidt HH, Stasch JP. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 5: 755-768, 2006. doi:10.1038/nrd2038.
4. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barberà J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol Ç, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Völler H, Luis Zamorano J. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37: 67-119, 2016. doi:10.1093/ eurheartj/ehv317.
5. Hervé C, Beyne P, Jamault H, Delacoux E. Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J Chromatogr B Biomed Appl 675: 157-161, 1996. doi:10.1016/0378-4347(95)00341-X.
6. Hoffmann J, Wilhelm J, Marsh LM, Ghanim B, Klepetko W, Kovacs G, Olschewski H, Olschewski A, Kwapiszewska G. Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Am J Respir Crit Care Med 190: 98-111, 2014. doi:10.1164/rccm.201401-0037OC.
7. Jain PP, Leber R, Nagaraj C, Leitinger G, Lehofer B, Olschewski H, Olschewski A, Prassl R, Marsh LM. Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries. Int J Nanomedicine 9: 3249-3261, 2014. doi:10.2147/IJN.S63190.
8. Jasiewicz M, Moniuszko M, Pawlak D, Knapp M, Rusak M, Kazimierczyk R, Musial WJ, Dabrowska M, Kaminski KA. Activity of the kynurenine pathway and its interplay with immunity in patients with pulmonary arterial hypertension. Heart 102: 230-237, 2016. doi:10.1136/ heartjnl-2015-308581.
9. Lewis GD, Ngo D, Hemnes AR, Farrell L, Domos C, Pappagianopoulos PP, Dhakal BP, Souza A, Shi X, Pugh ME, Beloiartsev A, Sinha S, Clish CB, Gerszten RE. Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension. J Am Coll Cardiol 67: 174-189, 2016. doi:10.1016/j.jacc. 2015.10.072.
10. Lob S, Konigsrainer A, Schafer R, Rammensee HG, Opelz G, Terness P. Levo-but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells. Blood 111: 2152-2154, 2008. doi:10.1182/blood-2007-10-116111.
11. Mancuso R, Hernis A, Agostini S, Rovaris M, Caputo D, Fuchs D and Clerici M. Indoleamine 2,3 dioxygenase (IDO) expression and activity in relapsing-remitting multiple slerosis. PLoS One 10: e0130715, 2015.
12. Mándi Y, Vécsei L. The kynurenine system and immunoregulation. J Neural Transm (Vienna) 119: 197-209, 2012. doi:10.1007/s00702-011-0681-y.
13. Mangge H, Stelzer I, Reininghaus EZ, Weghuber D, Postolache TT, Fuchs D. Disturbed tryptophan metabolism in cardiovascular disease. Curr Med Chem 21: 1931-1937, 2014. doi:10.2174/0929867321666140304105526.
14. Mangge H, Summers KL, Meinitzer A, Zelzer S, Almer G, Prassl R, Schnedl WJ, Reininghaus E, Paulmichl K, Weghuber D, Fuchs D. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome. Obesity (Silver Spring) 22: 195-201, 2014. doi:10.1002/oby.20491.
15. Nagaraj C, Tang B, Bálint Z, Wygrecka M, Hrzenjak A, Kwapiszewska G, Stacher E, Lindenmann J, Weir EK, Olschewski H, Olschewski A. Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries. Eur Respir J 41: 85-95, 2013. doi:10.1183/09031936.00211811.
16. Nagaraj C, Tang B, Nagy BM, Papp R, Jain PP, Marsh LM, Meredith AL, Ghanim B, Klepetko W, Kwapiszewska G, Weir EK, Olschewski H, Olschewski A. Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension. Eur Respir J 48: 1127-1136, 2016. doi:10.1183/13993003. 01814-2015.
17. Olschewski A, Li Y, Tang B, Hanze J, Eul B, Bohle RM, Wilhelm J, Morty RE, Brau ME, Weir EK, Kwapiszewska G, Klepetko W, Seeger W, Olschewski H. Impact of TASK-1 in human pulmonary artery smooth muscle cells. Circ Res 98: 1072-1080, 2006. doi:10.1161/01.RES. 0000219677.12988.e9.
18. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, Jugold M, Guillemin GJ, Miller CL, Lutz C, Radlwimmer B, Lehmann I, von Deimling A, Wick W, Platten M. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478: 197-203, 2011. doi:10.1038/nature10491.
19. Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 115: 165-175, 2014. doi:10.1161/CIRCRESAHA.113.301141.
20. Rafikova O, Meadows ML, Kinchen JM, Mohney RP, Maltepe E, Desai AA, Yuan JX, Garcia JG, Fineman JR, Rafikov R and Black SM. Metabolic changes precede the development of pulmonary hypertension in the monocrotaline exposed rat lung. PLoS One 11: e0150480, 2016.
21. Reininghaus EZ, McIntyre RS, Reininghaus B, Geisler S, Bengesser SA, Lackner N, Hecht K, Birner A, Kattnig F, Unterweger R, Kapfhammer HP, Zelzer S, Fuchs D, Mangge H. Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report. Bipolar Disord 16: 432-440, 2014. doi:10.1111/bdi.12166.
22. Sanni LA, Thomas SR, Tattam BN, Moore DE, Chaudhri G, Stocker R, Hunt NH. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol 152: 611-619, 1998.
23. Thomas SR, Stocker R. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 4: 199-220, 1999. doi:10.1179/135100099101534927.
24. Vécsei L, Szalárdy L, Fülöp F, Toldi J. Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 12: 64-82, 2013. doi:10.1038/nrd3793.
25. Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, Hahn M, Changsirivathanathamrong D, Wu BJ, Ball HJ, Thomas SR, Kapoor V, Celermajer DS, Mellor AL, Keaney JF Jr, Hunt NH, Stocker R. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 16: 279-285, 2010. doi:10.1038/nm.2092.
26. Xiao LD, Luo XB, Pi LG and Tang AG. Simultaneous determination of kynurenine and kynurenic acid concentrations in human serum by HPLC with dual wavelengths fluorescence detection. Clin Chim Acta 395: 178-180, 2008.
27. Xiao Y, Christou H, Liu L, Visner G, Mitsialis SA, Kourembanas S, Liu H. Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension. Am J Respir Crit Care Med 188: 482-491, 2013. doi:10.1164/rccm.201304-0700OC.